Keros Therapeutics, Inc. Annual Return On Equity in % from 2019 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Keros Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2019 to 2023.
  • Keros Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -41.7 %, a 8.1% increase year-over-year.
  • Keros Therapeutics, Inc. annual Return On Equity for 2023 was -46.7 %, a 6.4% decline from 2022.
  • Keros Therapeutics, Inc. annual Return On Equity for 2022 was -43.9 %, a 76.8% decline from 2021.
  • Keros Therapeutics, Inc. annual Return On Equity for 2021 was -24.9 %, a 30.3% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -46.7 -2.81 -6.4% Jan 1, 2023 Dec 31, 2023
2022 -43.9 -19.1 -76.8% Jan 1, 2022 Dec 31, 2022
2021 -24.9 +10.8 +30.3% Jan 1, 2021 Dec 31, 2021
2020 -35.7 -118 -143% Jan 1, 2020 Dec 31, 2020
2019 82.6 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.